ROIV
Roivant Sciences Ltd. · Healthcare
President & Immunovant CEO Eric Venker sold $6.6M of Roivant Sciences Ltd.
Sold$6,631,268
$33.16Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Mon, Jun 29 open, $33.85
- +4.1%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 11 close.
Traded Wed, Jun 24. Filed Fri, Jun 26, 6:13 PM ET, after the close. Returns use the Jun 29 open and the Aug 11 close. Not investment advice.